Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Journal of Bone Oncology|March 27, 2019
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture modelChiara Spadazzi, Federica Recine, Laura Mercatali, et al.
Clinical Lung Cancer|December 14, 2016
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of <sup>18</sup>FDG-PET/CTAlberto Bongiovanni, Federica Recine, Nada Riva, et al.
Pathologica|May 20, 2026
Detection of NTRK gene fusions in sarcomas: a comparative study of Pan-TRK immunohistochemistry, FISH, and RNA-Based NGSStefania Cocchi, Marco Gambarotti, Gabriella Gamberi, et al.
Frontiers in Pharmacology|December 11, 2023
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell linesChiara Casotti, Claudia Maria Hattinger, Maria Pia Patrizio, et al.
Oncology Letters|December 2, 2015
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature reviewAlberto Farolfi, Cristiano Ferrario, Michele Aquilina, et al.
Therapeutic Drug Monitoring|September 28, 2002
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patientsAntonello Di Paolo, Toni Ibrahim, Romano Danesi, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancerAntonello Di Paolo, Romano Danesi, Francesca Vannozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2023
Myoepithelial carcinoma of soft tissues and boneHisaki Aiba, Costantino Errani, Giovanni Ciani, et al.
Oncotargets and Therapy|March 7, 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasFederica Recine, Alberto Bongiovanni, Nada Riva, et al.
International Journal of Molecular Sciences|July 24, 2021
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune InterventionMarcella Tazzari, Laura Bergamaschi, Alessandro De Vita, et al.
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Journal of Bone Oncology|March 27, 2019
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture modelChiara Spadazzi, Federica Recine, Laura Mercatali, et al.
Clinical Lung Cancer|December 14, 2016
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of <sup>18</sup>FDG-PET/CTAlberto Bongiovanni, Federica Recine, Nada Riva, et al.
Pathologica|May 20, 2026
Detection of NTRK gene fusions in sarcomas: a comparative study of Pan-TRK immunohistochemistry, FISH, and RNA-Based NGSStefania Cocchi, Marco Gambarotti, Gabriella Gamberi, et al.
Frontiers in Pharmacology|December 11, 2023
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell linesChiara Casotti, Claudia Maria Hattinger, Maria Pia Patrizio, et al.
Oncology Letters|December 2, 2015
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature reviewAlberto Farolfi, Cristiano Ferrario, Michele Aquilina, et al.
Therapeutic Drug Monitoring|September 28, 2002
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patientsAntonello Di Paolo, Toni Ibrahim, Romano Danesi, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancerAntonello Di Paolo, Romano Danesi, Francesca Vannozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2023
Myoepithelial carcinoma of soft tissues and boneHisaki Aiba, Costantino Errani, Giovanni Ciani, et al.
Oncotargets and Therapy|March 7, 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasFederica Recine, Alberto Bongiovanni, Nada Riva, et al.
International Journal of Molecular Sciences|July 24, 2021
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune InterventionMarcella Tazzari, Laura Bergamaschi, Alessandro De Vita, et al.
Pageof 23